MODAG
Mareike Rode currently serves as the Personal Assistant to the CEO at AESKU.GROUP, a position held since June 2022. In addition, Mareike has been a Management Assistant at MODAG since November 2016. Prior experience includes the role of Executive Assistant to the CEO at Aesku.Group GmbH & Co. Kg from December 2008 to April 2020. With extensive experience supporting executive leadership, Mareike Rode has developed strong organizational and administrative skills throughout a diverse career.
This person is not in any teams
MODAG
MODAG aims to provide a novel approach for treating neurodegenerative diseases by combining targeted small molecule therapeutics with the right diagnostic tools. Their first objective is to demonstrate clinical proof-of-concept with their lead compound anle138b in Multiple System Atrophy (MSA) seeking to halt the progression and provide a firstdisease-modifying therapeutic.This success will allow us to apply their technology to similar diseases such as Parkinson’s and other synucleinopathies with the goal of dissolving disease-related intra-cellular oligomers, thereby reducing their toxic properties.MODAG is comprised of experts in the clinical research and neurodegenerative disease space and supported by grants from leading patient organizations including the Michael J Fox Foundation, Cure Parkinson's Trust and Parkinson’s UK.